Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 13;13(6):1457.
doi: 10.3390/biomedicines13061457.

Regulatory Genetic Networks by microRNAs: Exploring Genomic Signatures in Cervical Cancer

Affiliations
Review

Regulatory Genetic Networks by microRNAs: Exploring Genomic Signatures in Cervical Cancer

Carlos Pérez-Plasencia et al. Biomedicines. .

Abstract

Cervical cancer remains a significant global health concern, impacting over half a million women annually. The primary cause is a persistent infection with hr-HPV, which disrupts various cellular processes crucial for normal function. This disruption leads to genetic instability, including changes in the expression of microRNAs and their corresponding host genes, with far-reaching consequences for cellular regulation. Researchers have widely utilized high-throughput technologies to analyze gene expression in cervical cancer, aiming to identify distinct molecular signatures of microRNAs and genes through genomic analysis. However, discrepancies among studies have been noted, possibly due to variations in sample collection, technological platforms, and data processing methods such as normalization and filtering. Therefore, it is essential to synthesize findings from diverse studies to comprehensively understand the molecular mechanisms of regulatory genetic networks involved in the initiation and progression of cervical cancer. This review examined the evidence detailing the role of microRNA signatures and their target genes in cervical carcinogenesis and disease advancement. The accumulated data suggest the presence of widespread regulatory genetic networks active in both precancerous and cancerous cervical cells, potentially acting as key drivers of this malignancy. Identifying these molecular genomic signatures could open new avenues for developing therapeutic strategies for cervical cancer, particularly in the realm of precision medicine.

Keywords: regulatory genetic networks by microRNAs in cervical cancer.

PubMed Disclaimer

Conflict of interest statement

None of the authors has any financial conflict of interest related to the submitted manuscript.

Figures

Figure 1
Figure 1
PRISMA FLOW DIAGRAM. Prisma flow diagram, which includes a search of database records, research registers, and clinical trials.
Figure 2
Figure 2
Visualization of the regulatory genetic network of miR-21-5p showing the main features and several network layouts. The central panel shows a network in a circular-tripartite layout, and the surrounding panels provide functions for network analysis and customization. The central panel depicts-miR-21-5p and shows the target genes and 25 hits of the MAPK signaling pathway. The regulatory genetic network of the miR-21-5p was generated using miRNet version 2.0 website platform.

Similar articles

References

    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Loopik D.L., Bentley H.A., Eijgenraam M.N., IntHout J., Bekkers R.L.M., Bentley J.R. The natural history of cervical intraepithelial neoplasia grades 1, 2, and 3: A systematic review and meta-analysis. J. Low. Genit. Tract. Dis. 2021;25:221–231. doi: 10.1097/LGT.0000000000000604. - DOI - PubMed
    1. Lauby-Secretan B., Mackie A., Wentzensen N. The IARC perspective on cervical cancer screening. N. Engl. J. Med. 2022;386:607–608. doi: 10.1056/NEJMc2119177. - DOI - PubMed
    1. Cox J.T., Castle P.E., Behrens C.M., Sharma A., Wright T.C., Jr., Cuzick J., Athena HPV Study Group Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: Results from the ATHENA HPV study. Am. J. Obstet. Gynecol. 2013;208:184.e1–184.e11. doi: 10.1016/j.ajog.2012.11.020. - DOI - PubMed
    1. Bahrami A., Hasanzadeh M., Shahidsales S., Farazestanian M., Hassanian S.M., Moetamani A.M., Maftouh M., Gharib M., Yousefi Z., Kadkhodayan S., et al. Genetic susceptibility in cervical cancer: From bench to bedside. J. Cell Physiol. 2018;233:1929–1939. doi: 10.1002/jcp.26019. - DOI - PubMed

LinkOut - more resources